March 28 (Reuters) - Elixinol Wellness Ltd (EXL) :
- STRATEGIC REVIEW UPDATE-EXL.AX
- ANNOUNCES PRELIMINARY OUTCOMES OF STRATEGIC REVIEW UNDERTAKEN TO ADDRESS CHALLENGES RESULTING FROM CURRENT STATUS OF CBD SECTOR
- FINDINGS FROM STRATEGIC REVIEW IDENTIFIED OPPORTUNITIES THAT SEES TO REDUCE OPERATING COSTS BY ABOUT A$3.2M ON ANNUALISED BASIS
- RESIGNATION OF GLOBAL CEO OLIVER HORN, EFFECTIVE 8 APRIL 2022
- RON DUFFICY, CURRENT GLOBAL CFO, TO BE APPOINTED AS INTERIM GLOBAL CEO, EFFECTIVE 8 APRIL 2022
- DECIDED TO BRING FORWARD COST REDUCTIONS TO BETTER POSITION CO FOR CURRENT MARKET ENVIRONMENT
- Forums
- ASX - By Stock
- EXL
- News: EXL Elixinol Wellness Announces Preliminary Outcomes Of Strategic Review Undertaken To...
EXL
elixinol wellness limited
Add to My Watchlist
0.00%
!
1.9¢

News: EXL Elixinol Wellness Announces Preliminary Outcomes Of Strategic Review Undertaken To...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.373M |
Open | High | Low | Value | Volume |
1.9¢ | 2.0¢ | 1.9¢ | $4.255K | 221.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 201701 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.8¢ | 227778 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 201701 | 0.015 |
3 | 116290 | 0.014 |
1 | 81140 | 0.013 |
2 | 170909 | 0.011 |
1 | 104891 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.018 | 227778 | 1 |
0.020 | 385254 | 5 |
0.021 | 46491 | 1 |
0.022 | 186250 | 2 |
0.023 | 150000 | 1 |
Last trade - 11.55am 12/08/2025 (20 minute delay) ? |
Featured News
EXL (ASX) Chart |